Full Breakdown
Impact of Trump's Remarks on Acetaminophen Prescriptions for Pregnant Women
3/11/2026, 12:49:20 AM
Overview of the Core Event
A recent study published in *The Lancet* highlights the significant impact of President Donald Trump's statements on acetaminophen (Tylenol) during a September 2025 White House briefing. Trump advised pregnant women to avoid the medication, claiming it could cause autism, despite a lack of scientific evidence supporting this assertion. Following his remarks, prescriptions for acetaminophen among pregnant women decreased by approximately 10%, while prescriptions for non-pregnant women remained stable.
Key Findings from the Study
Researchers analyzed data from over 1,600 hospitals and 37,000 clinics across the United States, focusing on weekly prescribing trends before and after Trump's comments. The study revealed that the decline in acetaminophen prescriptions was notable among pregnant women aged 15 to 44. In contrast, there was no significant change in prescriptions for women who were not pregnant during the same period. This suggests that the president's statements may have influenced both patient behavior and clinician prescribing practices.
Dr. Michael Barnett, a senior researcher at Brown University, noted that the briefing represented an unusual method of disseminating medical information, which bypassed standard checks for accuracy. He emphasized that political leaders can significantly influence health behaviors, even in the absence of new evidence regarding medical treatments.
Increase in Leucovorin Prescriptions
In addition to the decrease in acetaminophen prescriptions, the study also found a 93% increase in outpatient prescriptions for leucovorin, a drug that has been suggested as a potential treatment for autism but is not included in standard treatment guidelines. Most of these prescriptions were for children diagnosed with autism, who represent a small fraction of the overall patient population analyzed.
Criticism from the Medical Community
The medical community has expressed concern over the implications of Trump's statements. The *American College of Obstetricians and Gynecologists* (ACOG) reiterated that acetaminophen is safe for use during pregnancy when taken under medical guidance. Critics argue that misinformation regarding acetaminophen and its alleged links to autism is growing, potentially endangering public health.
Dr. Jeremy Samuel Faust, the lead researcher of the study, remarked on the surprising nature of the findings, indicating that the influence of political figures on medical practices is troubling. He stated, “Unfortunately, they're claiming breakthroughs that simply haven't occurred,” highlighting the disconnect between public statements and scientific evidence.
Official Statements & Responses
The ACOG has maintained that acetaminophen is safe for pregnant women when used appropriately. The organization has also condemned the spread of misinformation regarding the drug's safety and its alleged connection to autism.
Conflicting Reports & Gaps
While the study indicates a clear decline in acetaminophen prescriptions for pregnant women, it remains unclear whether this change reflects shifts in patient demand or clinician decision-making. The lack of definitive data on the motivations behind these changes presents a gap in understanding the full impact of Trump's comments.
Verbatim Quotes
- “Don’t take Tylenol. Don’t take it. Fight like hell not to take it,” — Donald Trump, President of the United States
- “The results show just how much political leaders can steer health behavior even when there has been no change in the evidence for these therapies.” — Dr. Michael Barnett, Senior Researcher
- “Unfortunately, they're claiming breakthroughs that simply haven't occurred.” — Dr. Jeremy Samuel Faust, Lead Researcher
